Iron metabolism
Iron in the body exists in the following forms: Incorporated into Hb (80%) Myoglobin, Enzymes,Cytochromes (15%) Stored iron in the form of ferritin/hemosiderin. Plasma transferrin-bound iron.
( divalent metal transporter 1)
 
Iron exists in 2 forms: Inorganic/non-heme iron (90%) Fe 3+  (less soluble) Organic/heme iron (10%) Fe 2+  (more soluble) To be soluble, Ferric (Fe 3+ ) needs to be reduced to Ferrous (Fe 2+ ). The enzyme that does this is called  Duodenal cytochrome b  (Dcytb) This enzyme is  Vitamin C dependent .
From the gut lumen, iron needs to be moved into the  enterocyte  before getting to the bloodstream. Therefore, it needs a transporter to do this. Inorganic iron uses  DMT1   Organic iron uses  HCP1
Once in the enterocyte, iron is moved to the bloodstream. Fe 2+  is transported out by  ferroportin1 (FPN) Once it leaves the enterocyte, the Fe 2+  changes back to Fe 3+  by  Hephaestin.
Once in the bloodstream, Fe 3+  couples with Transferrin (Tf) forming a  Tf-Fe complex. Tf-Fe complex meets up with transferrin receptor 1 ( TfR1 ) in most cells. Proton ATPase  drops the pH in the endosome to release Fe 3+  from Tf. This reduction is achieved by  Steap3.
Macrophages engulfs old RBCs and releases heme.  Heme contains  protoporphyrin  and  Fe . Heme oxygenase  separates them and Fe is then stored as  ferritin.
Transferrin Major transporter  for iron trafficking through the  plasma . Increased  in iron deficiency. Rare disease:  Hypotransferrinemia . Characterized by low transferrin level, severe iron deficiency anemia and iron overloading.
Serum soluble transferrin receptor High transferrin receptor= high Erythroid mass. Causes for  low transferrin receptor : erythroid  hypo plasia. Aplastic anemia CRF Causes for  raised transferrin receptor : erythroid hyperplasia. Chronic hemolysis Thalassemia Iron deficiency (absence of erythroid hyperplasia) Not elevated  in anemia of chronic disease.
Transferrin  saturation Reduced : when iron supply is reduced. Iron deficiency anemia Anemia of chronic disease Ferroportin mutation Increased : when iron supply is in excess. Hemochromatosis Aplastic anemia Sideroblastic anemia Ineffective erythropoiesis. Liver disease with reduced transferrin synthesis.
Ferritin Cellular storage protein for iron. Plasma level reflects  overall iron stores. Also an acute phase reactant. Orchestrates cellular defense against oxidative stress and inflammation.
When body gets inflammation, the normal response is to save the iron (keep it in storage) so that it will be less available to the microbes. Raised ferritin  = Inflammation. Low ferritin =  iron deficiency anemia (99%) Raised ferritin but no infection/inflammation =  Iron overload. Extremely high ferritin = hemophagocytic lymphohistiocytosis.
Hepcidin Hepatic Bactericidal Protein. Negative regulator of iron metabolism. Actions: It inhibits intestinal transport. Blocks Fe transport across placenta. Induces Fe sequestration in macrophages. If  low iron stores  = hepcidin expression  reduced . If  high iron stores  = hepcidin expression  increased. Molecular target  of Hepcidin is  Ferroportin.
Here’s how it works… When iron is low, Hepcidin expression is reduced. Leads to increased ferroportin expression. Therefore, more transport of Fe from cells to blood bound by Tf.
Hepcidin  decreased  in: Hypoxia  Anemia Iron deficiency. Hepcidin  increased  in: Inflammation  leading to: low transferrin Sat (low iron saturation) increased ferritin (storage of iron) anemia. Inappropriately decreased  in chronic hemolytic anemia and thalassemias.
Ferro port in Major ex port er of iron. Transports iron from mother to fetus Transferring absorbed iron from enterocytes into the circulation. Allow macrophages to recycle iron from damaged red cells back into the circulation.
When  hepcidin  level  increase , Hepdicin  binds to ferroportin . Induces  internalisation and lysosomal  degradation . Therefore,  reduces amount of iron released  into circulation from duodenal cells and macrophages.
 
 

Iron metabolism

  • 1.
  • 2.
    Iron in thebody exists in the following forms: Incorporated into Hb (80%) Myoglobin, Enzymes,Cytochromes (15%) Stored iron in the form of ferritin/hemosiderin. Plasma transferrin-bound iron.
  • 3.
    ( divalent metaltransporter 1)
  • 4.
  • 5.
    Iron exists in2 forms: Inorganic/non-heme iron (90%) Fe 3+ (less soluble) Organic/heme iron (10%) Fe 2+ (more soluble) To be soluble, Ferric (Fe 3+ ) needs to be reduced to Ferrous (Fe 2+ ). The enzyme that does this is called Duodenal cytochrome b (Dcytb) This enzyme is Vitamin C dependent .
  • 6.
    From the gutlumen, iron needs to be moved into the enterocyte before getting to the bloodstream. Therefore, it needs a transporter to do this. Inorganic iron uses DMT1 Organic iron uses HCP1
  • 7.
    Once in theenterocyte, iron is moved to the bloodstream. Fe 2+ is transported out by ferroportin1 (FPN) Once it leaves the enterocyte, the Fe 2+ changes back to Fe 3+ by Hephaestin.
  • 8.
    Once in thebloodstream, Fe 3+ couples with Transferrin (Tf) forming a Tf-Fe complex. Tf-Fe complex meets up with transferrin receptor 1 ( TfR1 ) in most cells. Proton ATPase drops the pH in the endosome to release Fe 3+ from Tf. This reduction is achieved by Steap3.
  • 9.
    Macrophages engulfs oldRBCs and releases heme. Heme contains protoporphyrin and Fe . Heme oxygenase separates them and Fe is then stored as ferritin.
  • 10.
    Transferrin Major transporter for iron trafficking through the plasma . Increased in iron deficiency. Rare disease: Hypotransferrinemia . Characterized by low transferrin level, severe iron deficiency anemia and iron overloading.
  • 11.
    Serum soluble transferrinreceptor High transferrin receptor= high Erythroid mass. Causes for low transferrin receptor : erythroid hypo plasia. Aplastic anemia CRF Causes for raised transferrin receptor : erythroid hyperplasia. Chronic hemolysis Thalassemia Iron deficiency (absence of erythroid hyperplasia) Not elevated in anemia of chronic disease.
  • 12.
    Transferrin saturationReduced : when iron supply is reduced. Iron deficiency anemia Anemia of chronic disease Ferroportin mutation Increased : when iron supply is in excess. Hemochromatosis Aplastic anemia Sideroblastic anemia Ineffective erythropoiesis. Liver disease with reduced transferrin synthesis.
  • 13.
    Ferritin Cellular storageprotein for iron. Plasma level reflects overall iron stores. Also an acute phase reactant. Orchestrates cellular defense against oxidative stress and inflammation.
  • 14.
    When body getsinflammation, the normal response is to save the iron (keep it in storage) so that it will be less available to the microbes. Raised ferritin = Inflammation. Low ferritin = iron deficiency anemia (99%) Raised ferritin but no infection/inflammation = Iron overload. Extremely high ferritin = hemophagocytic lymphohistiocytosis.
  • 15.
    Hepcidin Hepatic BactericidalProtein. Negative regulator of iron metabolism. Actions: It inhibits intestinal transport. Blocks Fe transport across placenta. Induces Fe sequestration in macrophages. If low iron stores = hepcidin expression reduced . If high iron stores = hepcidin expression increased. Molecular target of Hepcidin is Ferroportin.
  • 16.
    Here’s how itworks… When iron is low, Hepcidin expression is reduced. Leads to increased ferroportin expression. Therefore, more transport of Fe from cells to blood bound by Tf.
  • 17.
    Hepcidin decreased in: Hypoxia Anemia Iron deficiency. Hepcidin increased in: Inflammation leading to: low transferrin Sat (low iron saturation) increased ferritin (storage of iron) anemia. Inappropriately decreased in chronic hemolytic anemia and thalassemias.
  • 18.
    Ferro port inMajor ex port er of iron. Transports iron from mother to fetus Transferring absorbed iron from enterocytes into the circulation. Allow macrophages to recycle iron from damaged red cells back into the circulation.
  • 19.
    When hepcidin level increase , Hepdicin binds to ferroportin . Induces internalisation and lysosomal degradation . Therefore, reduces amount of iron released into circulation from duodenal cells and macrophages.
  • 20.
  • 21.